Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Steroids ; 78(14): 1332-8, 2013 Dec 20.
Article in English | MEDLINE | ID: mdl-24145007

ABSTRACT

One-pot synthesis of an 18-norsteroid compound, 13(R),14(R)-epoxy-17ß-methyl-20(S)-hydroxyl-18-nor-pregna-4-en-3-one has been achieved with peracetic acid/acetic acid under a mild condition, via a proved tandem epoxidation-rearrangement-epoxidation sequence. Its structure was designated on the basis of NMR and X-ray crystallography data.


Subject(s)
20-alpha-Dihydroprogesterone/analogs & derivatives , Biological Products/chemical synthesis , Epoxy Compounds/chemical synthesis , Norprogesterones/chemical synthesis , 20-alpha-Dihydroprogesterone/chemical synthesis , Acetic Acid/chemistry , Catalysis , Crystallography, X-Ray , Magnetic Resonance Spectroscopy , Molecular Structure , Peracetic Acid/chemistry
2.
Steroids ; 65(5): 266-74, 2000 May.
Article in English | MEDLINE | ID: mdl-10751638

ABSTRACT

The progestational activity of second- and third-generation progestins in oral contraceptives were markedly increased by addition of an 18-methyl group. A new progestin, the 18-methyl analog of Nestorone, 16-methylene-17alpha-hydroxy-18-methyl-19-norpregn-4-ene-3,2 0-dione acetate (10), was synthesized. The relative binding affinity and biologic activity of 10 was compared with Nestorone, levonorgestrel, and progesterone using a binding assay for rat progesterone receptors, the Clauberg assay in the rabbit, and by assessing pregnancy maintenance in the rat. These studies, as summarized in Table 4, show that 10 is three to ten times more potent than Nestorone. The addition of the 18-methyl group to Nestorone markedly increased its potency as noted above, but is unlikely to change its rate of delivery from sustained release systems. 10 should be ideally suited for administration by implants or small skin patches.


Subject(s)
Norprogesterones/chemical synthesis , Norprogesterones/pharmacology , Animals , Biological Assay , Contraceptive Agents, Female/pharmacology , Dose-Response Relationship, Drug , Endometrium/drug effects , Female , Levonorgestrel/pharmacology , Male , Pregnancy , Pregnancy Maintenance/drug effects , Progesterone/analogs & derivatives , Progesterone/pharmacology , Progesterone Congeners/chemical synthesis , Progesterone Congeners/pharmacology , Rabbits , Rats , Rats, Sprague-Dawley
3.
Steroids ; 62(5): 403-8, 1997 May.
Article in English | MEDLINE | ID: mdl-9178426

ABSTRACT

16-Methylene-17 alpha-hydroxy-19-norpregn-4-ene-3,20-dione 1 and its 17 alpha-acylated derivatives were synthesized. The length of the 17 alpha-side-chain ranges from C2-C6. As anticipated, compound 1 did not show any progestational activity or receptor binding activity; whereas, the acylated compounds, especially the butyrate, showed remarkable ability to bind to progesterone receptors. These compounds also showed progestational activity in an in vitro T47D cell culture assay in which progestins increase alkaline phosphatase activity and in an in vivo ovulation inhibition assay. All of the compounds synthesized were without estrogenic activities. The results showed that acylation of 16-methylene-17 alpha-hydroxy-19-norprogesterone can increase progestational activity. The progestational activities of these compounds varied with the 17 alpha-side chain.


Subject(s)
Contraceptive Agents, Female/chemical synthesis , Norprogesterones/chemical synthesis , Progesterone Congeners/chemical synthesis , Animals , Female , Humans , Norprogesterones/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Progesterone/metabolism
4.
Nucl Med Biol ; 22(7): 915-20, 1995 Oct.
Article in English | MEDLINE | ID: mdl-8547889

ABSTRACT

For the synthesis of [18F]Fluoro-Org 6141 via a nucleophilic substitution reaction with 18F-, the tosyl group was chosen as the leaving group because of its stability and excellent leaving group ability. The biodistribution of the high affinity and moderate lipophilicity (log P = 2.66, calculated value) ligand [18F]Fluoro-Org 6141 (specific activity 8.2 to 37 TBq/mmol, yield 10% at EOB) was examined in sham adrenalectomized (sADX) and adrenalectomized (ADX) male Wistar rats. Two days after ADX or sADX, the animals were anesthetized and 0.37 to 1.85 MBq of [18F]Fluoro-Org 6141 was administered intravenously. Kinetics of 18F activity uptake were monitored for 3 h using a stationary double-headed positron emission tomography (PET) camera, and the biodistribution was assessed by ex vivo determination of radioactivity in several tissues and different brain areas. One hour after injection of the radioligand, the bladder, kidney, liver, trachea, and bone of sADX animals contained more concentration on a wet weight basis than blood. Three hours post injection, radioactivity was retained in bladder, trachea, and bone. The accumulation of radioactivity in brain corresponded to the concentration of activity in the blood within the first hours after injection. ADX animals showed a higher uptake of 18F activity in spleen, testes, and brain areas (hippocampus and brainstem) but a lower uptake in bone than sADX rats. PET scans suggested that 18F activity uptake in the brain had not yet reached a maximum at this interval. Although [18F]Fluoro-Org 6141 is not useful for PET studies of glucocorticoid receptors (GRs), the results obtained with this compound indicate a synthetic strategy suitable for the synthesis of high-affinity radioligands for GRs.


Subject(s)
Fluorine Radioisotopes , Norprogesterones/chemical synthesis , Norprogesterones/pharmacokinetics , Receptors, Glucocorticoid/analysis , Animals , Drug Stability , Fluorine Radioisotopes/chemistry , Isotope Labeling/methods , Ligands , Male , Radioligand Assay , Rats , Rats, Wistar , Tissue Distribution , Tomography, Emission-Computed
5.
Bioconjug Chem ; 5(3): 182-93, 1994.
Article in English | MEDLINE | ID: mdl-7918738

ABSTRACT

We have prepared and evaluated three metal conjugates of a progestin-monoamine-monoamide (MAMA') bisthiol chelate system. These conjugates of rhenium and technetium-99 and -99m, are structural analogs of the bisamino-bisthiol (BAT) conjugates we have described recently, but the MAMA' chelate, being more polar than the BAT system, gives a conjugate that is much less lipophilic, having an octanol-water partition coefficient that is nearly 80-fold lower. In competitive binding assays, the Re- and 99Tc-MAMA'-progestin conjugates bind to the progesterone receptor with affinities greater than that of progesterone itself, and in a direct binding assay, the equilibrium dissociation constant (Kd) of the 99mTc-MAMA' conjugate was 0.97 nM. As is typical for 11 beta-substituted progestins, these conjugates also have substantial binding affinity for glucocorticoid receptors. In tissue distribution studies in immature female rats, the progestin-99mTc-MAMA' conjugates show selective uptake for principal target tissue (such as uterus) over that of blood and nontarget tissue (such as muscle); these uptake ratios reach maximum levels of 5 and 4, respectively. Uptake by fat, liver, and kidney is quite high; however, only the uptake in uterus is displaceable upon coinjection of the selective progestin ORG2058. Metabolism studies show that the radioactivity in the uterus is essentially unmetabolized out to 4 h, while liver activity is completely due to metabolites. Other tissues show an intermediate fraction of unmetabolized conjugates that decreases with time. The in vivo behavior of the progestin-99mTc-MAMA' conjugate is similar to that of the labeled BAT conjugate: its uptake selectivity is somewhat greater than that of the BAT conjugate, but its target tissue uptake is lower. Factors that may be responsible for limiting the target tissue uptake properties of these conjugates are their moderate affinity for progesterone receptor, their substantial binding to glucorticoid receptors, and their large overall molecular size.


Subject(s)
Progesterone Congeners/chemical synthesis , Animals , Chelating Agents , Female , In Vitro Techniques , Mifepristone/chemical synthesis , Mifepristone/chemistry , Mifepristone/pharmacokinetics , Models, Molecular , Norprogesterones/chemical synthesis , Norprogesterones/chemistry , Norprogesterones/pharmacokinetics , Progesterone Congeners/chemistry , Progesterone Congeners/pharmacokinetics , Rats , Rats, Sprague-Dawley , Rhenium , Technetium , Tissue Distribution
6.
Cancer Lett ; 59(2): 125-32, 1991 Aug.
Article in English | MEDLINE | ID: mdl-1884369

ABSTRACT

Three 21-fluoro-progestins were investigated as potential imaging agents for the in vivo assessment of human progesterone receptor positive neoplasms with positron emission tomography. In competitive binding assays these compounds demonstrated high specificity, competing only for progesterone receptors. Binding to other steroid receptor types was negligible. Based on its high affinity binding, 21-fluoro-16 alpha-methyl-19-norprogesterone was selected for further evaluation in vivo. Tissue distribution studies in immature estrogen primed female rats revealed high uterine uptake of 21-[18F]fluoro-16 alpha-methyl-19-norprogesterone ([18F]FMNP). At 60 min after injection the ratio of uptake of radioactivity by uterine tissue to that of blood was 7. This ratio increased to 24 at 180 min. A selective decrease in uterine uptake was observed after administration of [18F]FMNP with excess unlabelled progestin. Rats bearing hormone responsive MT-W9A mammary adenocarcinomas were used to examine [18F]FMNP for tumour uptake. Animals were used irrespective of the phase of the estrous cycle. At 180 min the uterus to blood ratio and the tumour to blood ratio ranged from 3 to 20 and 3 to 17, respectively. Uterine and tumour tissue was assayed for cytosolic estrogen and progesterone receptors using a dextran-coated charcoal method and Scatchard plot analysis. The results indicate that the in vivo uptake of [18F]FMNP by uterine and mammary tumour tissue correlates well with the progesterone receptor concentration (rs = 0.98 and rs = 0.88, respectively). It is concluded that the uptake of [18F]FMNP by progesterone receptor positive tissue in vivo is primarily receptor related and that this uptake is attributable to the progesterone receptor. The study demonstrates the potential applicability of [18F]FMNP and positron emission tomography for imaging progesterone receptor positive neoplasms.


Subject(s)
Mammary Neoplasms, Experimental/metabolism , Norprogesterones/pharmacokinetics , Receptors, Progesterone/analysis , Tomography, Emission-Computed/methods , Uterus/metabolism , Animals , Female , Fluorine Radioisotopes , Norprogesterones/chemical synthesis , Rats , Rats, Inbred Strains , Tissue Distribution
7.
Yao Xue Xue Bao ; 26(8): 615-8, 1991.
Article in Chinese | MEDLINE | ID: mdl-1805524

ABSTRACT

Four new ST-1435 derivatives 4-7 were synthesized. Both 4 and 5 are mixture of Z- and E-isomers. 4 was separated into Z- and E-isomers by spinning TLC. Their binding ability to progesterone receptor was examined and found to be less than ST-1435.


Subject(s)
Contraceptive Agents, Female/chemical synthesis , Norprogesterones/chemical synthesis , Animals , Breast Feeding , Female , Lactation , Norprogesterones/metabolism , Rats , Receptors, Progesterone/metabolism
8.
J Med Chem ; 31(7): 1360-3, 1988 Jul.
Article in English | MEDLINE | ID: mdl-3260285

ABSTRACT

We have synthesized 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone (FENP), a high affinity ligand for the progesterone receptor, labeled with the positron-emitting radionuclide fluorine-18 (t1/2 = 110 min). The synthesis proceeds in two steps from 21-hydroxy-16 alpha-ethyl-19-norprogesterone and involves [18F]fluoride ion displacement of the 21-trifluoromethanesulfonate (21-triflate). This material is purified by HPLC and is obtained in 4-30% overall yield (decay corrected) within 40 min after the end of bombardment to produce [18F]fluoride ion. The effective specific activity, determined by competitive radioreceptor binding assays, is 700-1400 Ci/mmol. In vivo, [18F]FENP demonstrates highly selective, receptor-mediated uptake by the uterus of estrogen-primed rats; the uterus to blood and uterus to muscle ratios were respectively 26 and 16 at 1 h and 71 and 41 at 3 h after injection. The high target tissue selectivity of this uptake suggests that this compound may be useful for the in vivo imaging of progestin target tissues and receptor-rich tumors (such as human breast tumors) by positron emission tomography.


Subject(s)
Fluorine Radioisotopes , Norpregnenes/chemical synthesis , Norprogesterones/chemical synthesis , Receptors, Progesterone/metabolism , Tomography, Emission-Computed , Animals , Binding, Competitive , Chemical Phenomena , Chemistry , Chromatography, High Pressure Liquid , Estrogens/pharmacology , Female , Norprogesterones/metabolism , Norprogesterones/pharmacokinetics , Pregnenediones/metabolism , Progesterone/metabolism , Progesterone Congeners , Promegestone/metabolism , Rats , Rats, Inbred Strains , Uterus/drug effects , Uterus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...